Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 6NETWORK 2OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Disease 1

Interventions

Cisplatin 1038Cyclophosphamide 972Carboplatin 952Radiotherapy 890Bevacizumab 845Gemcitabine 817pembrolizumab 758Paclitaxel 738Docetaxel 733Oxaliplatin 704Capecitabine 646Fluorouracil 563Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 400Leucovorin 376Cytarabine 342Cetuximab 338Lenalidomide 326Trastuzumab 321Pemetrexed 314durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 277Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × OTHER × imetelstat × Clear all
NCT07549451 2026-04-24

Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
30 enrolled

Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡